Daniel Koller
Head Investment Management Team
finance
BB Biotech AG
Switzerland
Biography
Dr. Daniel Koller has been Head Investment Management Team at BB Biotech Inc. since 2010. He joined the BB Biotech Investment Management Team in 2004. His area of specialty is cardiovascular diseases. Before joining the Company he spent four years in the financial sector, initially as an equity analyst at UBS Warburg and then as a private equity investor at equity4life. Dr. Koller gained Masters degree in biochemistry and Doctorate in Philosophy in biotechnology from Eidgenoessische Technische Hochschule Zuerich (ETH), Institute of Biotechnology of Federal Institute of Technology Zurich.
Research Interest
Economics
